J. Robert Beck Named First Chief Academic Officer at Fox Chase Cancer Center
PHILADELPHIA (Sept. 17, 2007)—Fox Chase Cancer Center has named J. Robert "Bob" Beck, M.D., of Riverton, N.J., as the Center's first chief academic officer, effective immediately.
"The creation of this position reflects our rapidly expanding clinical and laboratory research activities and positions Fox Chase to maintain its elite status as one of the nation's top cancer centers," said president and . As a senior vice president, Beck will serve as a member of the Center's Leadership Council reporting to the president.
In his new role, Beck will be responsible for the office of sponsored research, office of business development and institutional review board as well as a number of core research facilities and information technology. He will also chair the Center's long term strategic space planning. Beck will also help foster academic collaborations with a wide variety of national and international universities, research institutions and oncologists. In addition, he will work to launch initiatives for more structured faculty development, mentoring and educational activities.
Prior to his new role, Beck served as deputy director of the population science division and as vice president for information services and chief information officer at Fox Chase.
Beck holds grants from the National Institutes of Health, the Commonwealth of Pennsylvania and the National Cancer Institute's Cancer Biomedical Informatics Grid (caBIG™).
Before joining Fox Chase in 2001, Beck was vice president for information, research and planning at Baylor College of Medicine in Houston, Texas. He was also a professor of pathology and professor of family and community medicine there.
Beck earned his undergraduate degree summa cum laude from Dartmouth College in 1974 and was elected to Phi Beta Kappa. He received his M.D. from Johns Hopkins University in 1978 and served his residency in pathology at Dartmouth-Hitchcock Medical Center. With a focus on clinical decision making, he completed a clinical fellowship in medicine at the New England Medical Center in 1982.
Beck was a member of the Dartmouth Medical School faculty and staff pathologist at Mary Hitchcock in Hanover, N.H., from 1982 until 1989. In 1989, he joined Oregon Health Sciences University as professor of pathology and medicine and was a staff clinical pathologist at University Hospital in Portland, Ore. He also directed the university's biomedical information communication center and was a professor of preventive medicine and public health.
Beck serves on the board of directors of IDM Pharma, a publicly traded cancer therapeutics company. He is also a board member of the nonprofit HealthGrid.US Alliance, a partnership of scientific, medical and technology professionals from academia, industry and government whose mission is to promote the application of advanced information technology to solve cutting-edge problems in biomedical sciences and health care.
A past editor-in-chief of Medical Decision Making, Beck served on the editorial boards of Disease Management and the Journal of Biomedical Informatics until last year. He was the interim executive director for the Houston Academy of Medicine – Texas Medical Center Library from 1999 to 2001 and was a member of its board of directors from 1992 until joining Fox Chase. Beck is a member of many professional and scientific societies, including the American College of Medical Informatics, Society for Medical Decision Making, and the College of American Pathologists.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Diana Quattrone at 215-728-7784.